66
Panelists discuss how subcutaneous (SC) therapy can improve adherence by minimizing treatment disruptions and simplifying logistics. They explore best practices for transitioning patients from intravenous (IV) to SC formulations, emphasizing the importance of education, monitoring, and gradual integration. The conversation underscores that streamlined delivery and patient familiarity promote long-term adherence and confidence in SC therapy as an equivalent yet more convenient alternative to IV treatment.
